2 completed, 1 recruiting. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Recruiting 1 |
Follow Nielsen Fernandez-Becker: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A First-in-Patient Study to Evaluate the Safety and Tolerability of HB-2121 as a Diagnostic for Celiac Disease HB-2121 - Celiac Disease | Phase 1 | Recruiting | Nielsen Fernandez-Becker | 20 | 2026-04-29 | 2026-07-28 |
| A First-in-human Study to Evaluate the Safety and Tolerability of HB-2121 as a Diagnostic for Celiac Disease HB-2121 - Celiac Disease, Healthy | Phase 1 | Completed | Nielsen Fernandez-Becker | 18 | 2025-08-26 | 2026-07-28 |
| PTG-100 for Patients With Celiac Disease PTG-100, Placebo - Celiac Disease | Phase 1 | Completed | Nielsen Fernandez-Becker | 12 | 2021-02-26 | 2022-05-23 |
Celiac Disease (3)
PTG-100 peptide (1)
United States (3)